Don't miss our upcoming webinar "Prostate Cancer Detection Powered by AI"! Hosted by Human Bytes and featuring: 👤 Kai Vilanova MD, PhD 👤 David Bazaga, Product Lead at Quibim. 🔎 This is the perfect opportunity to discover how #AI can support #ProstateCancer diagnosis and improve workflow and patient outcomes. Register here 👉 https://bit.ly/3VGfahz
💡Did you miss our latest in-depth discussion on the transformative role of #AI in the early detection of #ProstateCancer? We explored topics such as: 🔄 Operational limitations related to radiologist workforce. 💡 Future perspectives and upcoming clinical studies. 🔗 Integration of AI in improving patient outcomes. If you haven't seen it, you can find it here! https://bit.ly/3vCAHwJ #ProstateCancerWebinar #AIHealthcare #MedicalInnovation
📢 Attention Spanish speakers! You can now tune in to this episode of BioEmprendedores where our CEO, Dr Ángel Alberich-Bayarri, explains the history of Quibim and how he has managed to lead a team that has succeeded in expanding our company globally, with the ambition to transform imaging data into a catalyst for hashtag#PrecisionHealth to improve patient outcomes.
In medical imaging, when we mention the segmentation process this involves identifying and delineating a region of interest such as lesions, organs, healthy tissues, or structures, delineated across various modalities such as #MRI, CT, or PET. But why is an accurate segmentation so important? 🎯 At Quibim, the precision of our segmentation results is fundamental. This sophisticated tool not only characterizes the aggressiveness and heterogeneity of tumors but also serves as the foundation for developing advanced #AI-based algorithms capable of making predictions at both lesion and patient levels. Want to learn more about the power that an accurate segmentation in AI-driven solutions has? Read our latest blog written by Raúl Yebana Huertas and Victor Manuel Climent Villanueva, respectively Image Analysis Manager and Technician at Quibim 👉 https://bit.ly/3TupFSp
Today, we are proud to announce the official launch of QP-Liver, a tool that offers clinicians unprecedented insight into #liver health. This innovative technology uses advanced AI algorithms to precisely quantify tissue fat and iron from #MRI scans, facilitating early detection, accurate monitoring, and personalized treatment plans for liver disease. Its use enables the highest accuracy and empowers clinicians to make more informed diagnoses for patients with diffuse liver disease. ✅ Certified with CE and UKCA marks, QP-Liver is approved in the EU and the UK. Chronic liver disease, a major global health challenge, causes approximately 2 million deaths annually, according to the World Health Organization. QP-Liver addresses this burden by offering a novel, non-invasive diagnostic approach that outperforms traditional methods in accuracy and insight. By providing comprehensive information for steatosis and iron overload evaluation, our solution enhances clinical decision-making, reduces the need for invasive biopsies, and elevates #patientcare. Read everything about it here! bit.ly/3TM64NJ
